209 related articles for article (PubMed ID: 33141175)
21. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
22. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
23. Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system.
Hansen KR; Craig LB; Zavy MT; Klein NA; Soules MR
Menopause; 2012 Feb; 19(2):164-71. PubMed ID: 22189385
[TBL] [Abstract][Full Text] [Related]
24. Relationship of menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors.
Chemerinski A; Cameron K; Sammel M; Ginsberg J; Carlson C; Gracia C
J Cancer Surviv; 2020 Oct; 14(5):607-613. PubMed ID: 32323140
[TBL] [Abstract][Full Text] [Related]
25. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.
Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ
Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952
[TBL] [Abstract][Full Text] [Related]
26. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.
Harlow SD; Gass M; Hall JE; Lobo R; Maki P; Rebar RW; Sherman S; Sluss PM; de Villiers TJ;
J Clin Endocrinol Metab; 2012 Apr; 97(4):1159-68. PubMed ID: 22344196
[TBL] [Abstract][Full Text] [Related]
27. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition.
Yang YS; Hur MH; Kim SY; Young K
Menopause; 2011 Feb; 18(2):138-45. PubMed ID: 21341396
[TBL] [Abstract][Full Text] [Related]
28. A 10-year follow up of reproductive function in women treated for childhood cancer.
Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
[TBL] [Abstract][Full Text] [Related]
29. Acute onset of ovarian dysfunction in young females after start of cancer treatment.
Mörse H; Elfving M; Lindgren A; Wölner-Hanssen P; Andersen CY; Øra I
Pediatr Blood Cancer; 2013 Apr; 60(4):676-81. PubMed ID: 23015461
[TBL] [Abstract][Full Text] [Related]
30. Predicting chemotherapy-induced menopause using baseline and post-chemotherapy anti-Müllerian hormone levels: Results of a pilot study.
Martin HL; Ullah S; Abbas N; Scott-Hoy A; Kichenadasse G; Karapetis CS; Roy A; Sukumaran S; Ross DM; Khattak MA; Koczwara B
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1342. PubMed ID: 33660428
[TBL] [Abstract][Full Text] [Related]
31. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.
Janse F; Donnez J; Anckaert E; de Jong FH; Fauser BC; Dolmans MM
J Clin Endocrinol Metab; 2011 Apr; 96(4):1136-44. PubMed ID: 21289248
[TBL] [Abstract][Full Text] [Related]
32. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
Robertson DM; Lee CH; Baerwald A
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00172. PubMed ID: 33855196
[TBL] [Abstract][Full Text] [Related]
33. Cycle and hormone changes during perimenopause: the key role of ovarian function.
Burger HG; Hale GE; Dennerstein L; Robertson DM
Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
[TBL] [Abstract][Full Text] [Related]
34. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
35. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
[TBL] [Abstract][Full Text] [Related]
36. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
Anderson RA; Mansi J; Coleman RE; Adamson DJA; Leonard RCF
Eur J Cancer; 2017 Dec; 87():58-64. PubMed ID: 29117576
[TBL] [Abstract][Full Text] [Related]
37. Comparison of follicle-stimulating hormone, estradiol, ovarian volume, and antral follicle count, based on the Stages of Reproductive Aging Workshop system, among community-based women in China.
Sun N; Lin SQ; Lin HJ; He Z; Wang YH; Zhang Y; Chen FL; Jiang Y
Menopause; 2013 Jul; 20(7):736-41. PubMed ID: 23422866
[TBL] [Abstract][Full Text] [Related]
38. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
39. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging.
Harlow SD; Crawford S; Dennerstein L; Burger HG; Mitchell ES; Sowers MF;
Climacteric; 2007 Apr; 10(2):112-9. PubMed ID: 17453859
[TBL] [Abstract][Full Text] [Related]
40. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age.
Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
Menopause; 2011 May; 18(5):521-4. PubMed ID: 21178792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
